ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Renal Fibrosis Is Alleviated through Targeted Inhibition of IL-11-Induced Renal Tubular Epithelial-to-Mesenchymal Transition

Li, Yaqin; Luo, Congwei; Zeng, Yiqun; Zheng, Zerong; Tao, Danping; Liu, Qiao; Hong, Yiyu; Wang, Shuo; Long, Haibo*; Xu, Zhaozhong*南方医科大学
American Journal of Pathology2023-12DOI: 10.1016/j.ajpath.2023.07.005
2被引14阅读
引用收藏
分享

摘要

Renal fibrosis is a pathologic process that leads to irreversible renal failure without effective treatment. Epithelial-to-mesenchymal transition (EMT) plays a key role in this process. The current study found that aberrant expression of IL-11 is critically involved in tubular EMT. IL-11 and its receptor subunit alpha-1 (IL-11Ra1) were significantly induced in renal tubular epithelial cells (RTECs) in unilateral ureteral obstruction (UUO) kidneys, co-localized with transforming growth factor -01. IL-11 knockdown ameliorated UUO-induced renal fibrosis in vivo and transforming growth factor -01-induced EMT in vitro. IL-11 intervention directly induced the transdifferentiation of RTECs to the mesenchymal phenotype and increased the synthesis of profibrotic mediators. The EMT response induced by IL-11 was dependent on the sequential activation of STAT3 and extracellular signal-regulated kinase 1/2 signaling pathways and the up-regulation of metadherin in RTECs. Micheliolide (MCL) competitively inhibited the binding of IL-11 with IL-11Ra1, suppressing the activation of STAT3 and extracellular signal-regulated kinase 1/2-metadherin pathways, ultimately inhibiting renal tubular EMT and interstitial fibrosis induced by IL-11. In addition, treatment with dimethylaminomicheliolide, a pro -drug of MCL for in vivo use, significantly ameliorated renal fibrosis exacerbated by IL-11 in the UUO model. These findings suggest that IL-11 is a promising target in renal fibrosis and that MCL/dime-thylaminomicheliolide exerts its antifibrotic effect by suppressing IL-11/IL-11Ra1 interaction and blocking its downstream effects. (Am J Pathol 2023, 193: 1936-1952; https://doi.org/10.1016/ j.ajpath.2023.07.005)

学科与关键词

关键词
TGF-BETAMECHANISMSINTERLEUKIN-11ACTIVATIONMICE
相关
加载中…
  • Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition
    Zhou, Ruimei; Liao, Jiashun; Cai, Dunpeng; Tian, Qin; Huang, Enping; Lu, Tianming; Chen, Shi-You*; Xie, Wei-Bing*FASEB Journal, 2021, 35(3): e21381.被引 11
  • FoxM1 inhibition ameliorates renal interstitial fibrosis by decreasing extracellular matrix and epithelial-mesenchymal transition
    Wang, Yanhui; Zhou, Qiaoling*; Tang, Rong; Huang, Yuyu; He, TingJournal of Pharmacological Sciences, 2020, 143(4): 281-289.被引 13
  • Nicotinamide N-methyltransferase ameliorates renal fibrosis by its metabolite 1-methylnicotinamide inhibiting the TGF-β1/Smad3 pathway
    Zhang, Wenying; Rong, Guang; Gu, Jinge; Fan, Cuiling; Guo, Tingting; Jiang, Tingting; Deng, Weiqian; Xie, Jiayu; Su, Zhihua; Yu, Qimin; Mai, Jingyi; Zheng, Rinan; Chen, Xingling; Tang, Xun*; Zhang, Jun*FASEB Journal, 2022, 36(3): e22084.被引 14
查看全部 →

发表信息

论文状态
公开发表
期刊
American Journal of Pathology
发表日期
2023-12
卷期
第 193 卷, 第 12 期
页码
1936-1952
DOI
10.1016/j.ajpath.2023.07.005
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81900607]; National Natural Science Foundation of Guangdong Province, China [2019A1515011083]; Science and Technology Planning Project of Guangzhou, China [201707010286]

作者

  • L

    Li, Yaqin (第一作者)

    southern med univ

  • L

    Luo, Congwei

    southern med univ

查看全部 10 位作者收起作者
  • Z

    Zeng, Yiqun

    southern med univ

  • Z

    Zheng, Zerong

    southern med univ

  • T

    Tao, Danping

    southern med univ

  • L

    Liu, Qiao

    southern med univ

  • H

    Hong, Yiyu

    southern med univ

  • W

    Wang, Shuo

    southern med univ

  • L

    Long, Haibo (通讯)

    southern med univ

  • X

    Xu, Zhaozhong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417